HealthHCG CMD Warns Cancer Drug Price Caps May Hinder New Treatments
Ajai Kumar, CMD of HCG, stated that while the maximum retail price (MRP) of cancer drugs can be reduced, imposing a 30% trade margin cap on non-scheduled cancer drugs might prevent Indian patients from accessing new treatments. He described such price controls as 'thoughtless interference' that could limit availability of innovative cancer therapies in India.
NDTV Business·